BERTOTTI, Andrea

BERTOTTI, Andrea  

ONCOLOGIA  

Mostra records
Risultati 1 - 10 di 10 (tempo di esecuzione: 0.019 secondi).
Titolo Data di pubblicazione Autore(i) File
Derivation and charaterization of cancer initialling cells representative of metastatic colorectal cancer genetic heterogeneity 2015 V. Bigatto, P. Luraghi, E. Cipriano, G. _Reato, F.N.Orzan, R. Neggia, A. Bertotti, L. Trusolino, P.M.Comoglio, C. Boccaccio
EXPRESSION OF MET MRNA AS PROGNOSTIC MARKER IN MULTIPLE MYELOMA PATIENTS TREATED WITH NOVEL DRUGS 2010 Rocci A; Gambella M; Trusolino L; Gay F; Omedè P; Magarotto V; Bertotti A; Montefusco V; Crippa C; Patriarca F; Gilestro M; Liberati AM; Gaidano G; Di Raimondo F; Falcone A; Rossi G; Drandi D; Corradini P; Ladetto M; Comoglio PM; Boccadoro M; Palumbo A
Genome-wide CRISPR screens reveal Hippo pathway activation as a resistance mechanism in BRAF mutant colon cancer 2021 Brammeld, JS; Thorpe, H; Garcia, MA; Price, S; Young, J; Pfeifer, M; Lupo, B; Yusa, K; Trusolino, L; Garnett, M; Bertotti, A; Bakal, C; McDermott, U
High Expression of mRNA and Gene Amplification of Met In Myeloma Plasma Cells Characterize a More Aggressive Disease 2010 Alberto Rocci; Manuela Gambella; Simona Aschero; Ileana Baldi; Livio Trusolino; Federica Cavallo; Alessandra Larocca; Paola Omedè; Andrea Bertotti; Vittorio Montefusco; Claudia Crippa; Francesca Patriarca; Anna Marina Liberati; Antonietta Falcone; Gianluca Isaia; Daniela Drandi; Marco Ladetto; Paolo M. Comoglio; Giovannino Ciccone; Mario Boccadoro; and Antonio Palumbo
Identification and pre-clinical validation of surrogate soluble biomarkers correlating with therapeutic response to met inhibition 2010 Torti D; Bertotti A; Galimi F; Gastaldi S; Sassi F; Trusolino L
Met as a potential therapeutic target in basal-like breast cancer 2010 Gastaldi S; Bertotti A; Galimi F; Sassi F; Torti D; Smalley M; Trusolino L
Met as a potential therapeutic target in basal-like breast cancer: An in vivo approach in a stem-cell perspective 2009 Gastaldi S; Bertotti A; Bracco C; Galimi F; Torti D; Trusolino L
met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre-clinical model of human osteosarcoma 2009 Raffaella De Maria; Silvia Miretti; Selina Iussich; Martina Olivero;Emanuela Morello; Andrea Bertotti; James G. Christensen; Bartolomeo Biolatti; Roy A. Levine; Paolo Buracco; Maria Flavia Di Renzo
Met Over-Expression Is a Prognostic Factor for Myeloma Patients Treated with Novel Agents 2009 Albero Rocci; Francesca Gay; Livio Trusolino; Paola Omedè; Andrea Bertotti; Vittorio Montefusco; Claudia Crippa; Francesca Patriarca; Milena Gilestro; Anna M. Liberati; Fausto Rossini; Tommaso Caravita; Antonietta Falcone; Giuseppe Rossi; Daniela Drandi; Paolo Corradini; Marco Ladetto; Paolo M. Comoglio; Mario Boccadoro; Antonio Palumbo
MET SIGNALING REGULATES GROWTH, REPOPULATING POTENTIAL AND BASAL CELL-FATE COMMITMENT OF MAMMARY LUMINAL PROGENITORS: IMPLICATIONS FOR BASAL-LIKE BREAST CANCER. 2012 Paolo Accornero; Stefania Gastaldi; Francesco Sassi; Davide Torti; Silvia Miretti; Eugenio Martignani; Mario Baratta; Matthew J Smalley; Andrea Bertotti; Livio Trusolino